BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2112 related articles for article (PubMed ID: 32722671)

  • 1. The global burden of disease attributable to high body mass index in 195 countries and territories, 1990-2017: An analysis of the Global Burden of Disease Study.
    Dai H; Alsalhe TA; Chalghaf N; Riccò M; Bragazzi NL; Wu J
    PLoS Med; 2020 Jul; 17(7):e1003198. PubMed ID: 32722671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Risk Factor Collaborators
    Lancet; 2018 Nov; 392(10159):1923-1994. PubMed ID: 30496105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Forecasting Collaborators
    Lancet; 2024 May; 403(10440):2204-2256. PubMed ID: 38762325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Cirrhosis Collaborators
    Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):245-266. PubMed ID: 31981519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD 2015 Risk Factors Collaborators
    Lancet; 2016 Oct; 388(10053):1659-1724. PubMed ID: 27733284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 DALYs and HALE Collaborators
    Lancet; 2018 Nov; 392(10159):1859-1922. PubMed ID: 30415748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global burden of noncommunicable disease attributable to high body mass index in 195 countries and territories, 1990-2017.
    Lin X; Xu Y; Xu J; Pan X; Song X; Shan L; Zhao Y; Shan PF
    Endocrine; 2020 Aug; 69(2):310-320. PubMed ID: 32488838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the Global Burden of Disease Study 2017.
    Li N; Deng Y; Zhou L; Tian T; Yang S; Wu Y; Zheng Y; Zhai Z; Hao Q; Song D; Zhang D; Kang H; Dai Z
    J Hematol Oncol; 2019 Dec; 12(1):140. PubMed ID: 31864424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015.
    GBD 2015 Tobacco Collaborators
    Lancet; 2017 May; 389(10082):1885-1906. PubMed ID: 28390697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The global burden of disease attributable to ambient fine particulate matter in 204 countries and territories, 1990-2019: A systematic analysis of the Global Burden of Disease Study 2019.
    Sang S; Chu C; Zhang T; Chen H; Yang X
    Ecotoxicol Environ Saf; 2022 Jun; 238():113588. PubMed ID: 35525115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Risk Factors Collaborators
    Lancet; 2024 May; 403(10440):2162-2203. PubMed ID: 38762324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 DALYs and HALE Collaborators
    Lancet; 2017 Sep; 390(10100):1260-1344. PubMed ID: 28919118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The global burden of type 2 diabetes attributable to high body mass index in 204 countries and territories, 1990-2019: An analysis of the Global Burden of Disease Study.
    Zhang X; Wang X; Wang M; Hu B; Tang W; Wu Y; Gu J; Ni T; Li Q
    Front Public Health; 2022; 10():966093. PubMed ID: 36159296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Diabetes Collaborators
    Lancet; 2023 Jul; 402(10397):203-234. PubMed ID: 37356446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological trends of tracheal, bronchus, and lung cancer at the global, regional, and national levels: a population-based study.
    Deng Y; Zhao P; Zhou L; Xiang D; Hu J; Liu Y; Ruan J; Ye X; Zheng Y; Yao J; Zhai Z; Wang S; Yang S; Wu Y; Li N; Xu P; Zhang D; Kang H; Lyu J; Dai Z
    J Hematol Oncol; 2020 Jul; 13(1):98. PubMed ID: 32690044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring the global disease burden of polycystic ovary syndrome in 194 countries: Global Burden of Disease Study 2017.
    Liu J; Wu Q; Hao Y; Jiao M; Wang X; Jiang S; Han L
    Hum Reprod; 2021 Mar; 36(4):1108-1119. PubMed ID: 33501984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Oesophageal Cancer Collaborators
    Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):582-597. PubMed ID: 32246941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD 2015 Chronic Respiratory Disease Collaborators
    Lancet Respir Med; 2017 Sep; 5(9):691-706. PubMed ID: 28822787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD 2015 DALYs and HALE Collaborators
    Lancet; 2016 Oct; 388(10053):1603-1658. PubMed ID: 27733283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD Chronic Respiratory Disease Collaborators
    Lancet Respir Med; 2020 Jun; 8(6):585-596. PubMed ID: 32526187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 106.